Skip to main content
Log in

Booster dose of serogroup C meningococcal vaccine of value

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. De Wals P, Coudeville L, Trottier P, Chevat C, Erickson LJ, Nguyen VH.Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis. Vaccine 25: 5433-5440, No. 29, 20 Jul 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Booster dose of serogroup C meningococcal vaccine of value. Pharmacoecon. Outcomes News 534, 5 (2007). https://doi.org/10.2165/00151234-200705340-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705340-00011

Keywords

Navigation